DÄ internationalArchiveReferences
References

Clinical Practice Guideline

Methamphetamine-Related Disorders

Dtsch Arztebl Int 2017; 114(26): 455-61; DOI: 10.3238/arztebl.2017.0455

Gouzoulis-Mayfrank, E; Härtel-Petri, R; Hamdorf, W; Havemann-Reinecke, U; Mühlig, S; Wodarz, N

1.Milin S, Lotzin A, Degkwitz P, et al.: Amphetamin und Methamphetamin – Personengruppen mit missbräuchlichem Konsum und Ansatzpunkte für präventive Maßnahmen. Sachbericht. 2014. www.methstudie.de/ats-bericht.pdf (last accessed 2 June 2017).
2. Die Drogenbeauftragte der Bundesregierung, Bundesministerium für Gesundheit (BMG), Bundes­ärzte­kammer (BÄK), Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN): S3-Leitlinie Methamphetamin-bezogene Störungen. Leitlinienreport. 1st Edition. Version 1. doi.org/10.6101/AZQ/000337 (last accessed on 21 November 2016).
3. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF): Das AWMF-Regelwerk Leitlinien. München: Zuckschwerdt 2012.
4. Guidelines Development Working Party, Jenner J, Spain D, et al.: Management of patients with psychostimulant toxicity: guidelines for emergency departments. Canberra: Australian Government Department of Health and Ageing 2006.
5. Turning Point Alcohol and Drug Centre, Lee N, Johns L, et al.: No 14: Methamphetamine dependence and treatment. Fitzroy, Victoria: Turning Point Alcohol and Drug Centre 2007.
6. Shoptaw S, Huber A, Peck J, et al.: Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence. Drug Alcohol Depend 2006; 85: 12–8 CrossRef MEDLINE
7. Rawson RA, Marinelli-Casey P, Anglin MD, et al.: A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction 2004; 99: 708–17 CrossRef MEDLINE
8. Substance Abuse and Mental Health Services Administration (SAMHSA): Counselor‘s treatment manual: matrix intensive outpatient treatment for people with stimulant use disorders. Reprinted 2007. Rockville, MD: SAMHSA 2006.
9. Elkashef A, Vocci F, Hanson G, White J, Wickes W, Tiihonen J: Pharmacotherapy of methamphetamine addiction: an update. Subst Abus 2008; 29: 31–49 CrossRef MEDLINE PubMed Central
10. McCann DJ, Li SH: A novel, nonbinary evaluation of success and failure reveals bupropion efficacy versus methamphetamine dependence: reanalysis of a multisite trial. CNS Neurosci Ther 2012; 18: 414–8 CrossRef MEDLINE
11. Anderson AL, Li SH, Markova D, et al.: Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend 2015; 150: 170–4 CrossRef MEDLINE PubMed Central
12. Galloway GP, Newmeyer J, Knapp T, Stalcup SA, Smith D: Imipramine for the treatment of cocaine and methamphetamine dependence. J Addict Dis 1994; 13: 201–16 CrossRef MEDLINE
13. Galloway GP, Newmeyer J, Knapp T, Stalcup SA, Smith D: A controlled trial of imipramine for the treatment of methamphetamine dependence. J Subst Abuse Treat 1996; 13: 493–7 CrossRef
14. Anderson AL, Li SH, Biswas K, et al.: Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend 2012; 120: 135–41 CrossRef MEDLINE PubMed Central
15. Ling W, Shoptaw S, Hillhouse M, et al.: Double-blind placebo-controlled evaluation of the PROMETA protocol for methamphetamine dependence. Addiction 2012; 107: 361–9 CrossRef MEDLINE PubMed Central
16. Wang T, Shen B, Shi Y, Xiang P, Yu Z: Chiral separation and determination of R/S-methamphetamine and its metabolite R/S-amphetamine in urine using LC-MS/MS. Forensic Sci Int 2015; 246: 72–8 CrossRef MEDLINE
17. Rawson RA, Chudzynski J, Gonzales R, et al.: The impact of exercise on depression and anxiety symptoms among abstinent methamphetamine-dependent individuals in a residential treatment setting. J Subst Abuse Treat 2015; 57: 36–40 CrossRef MEDLINE PubMed Central
18. Dolezal BA, Chudzynski J, Storer TW, et al.: Eight weeks of exercise training improves fitness measures in methamphetamine-dependent individuals in residential treatment. J Addict Med 2013; 7: 122–8 CrossRef MEDLINE PubMed Central
19. Rostami R, Dehghani-Arani F: Neurofeedback training as a new method in treatment of crystal methamphetamine dependent patients: a preliminary study. Appl Psychophysiol Biofeedback 2015; 40: 151–61 CrossRef MEDLINE
20. Nejtek VA, Avila M, Chen LA, et al.: Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized double-blind trial. J Clin Psychiatry 2008; 69: 1257–66 CrossRef MEDLINE
21. Brown ES, Gabrielson B: A randomized, double-blind, placebo-controlled trial of citicoline for bipolar and unipolar depression and methamphetamine dependence. J Affect Disord 2012; 143: 257–60 CrossRef MEDLINE
22. Hellem TL, Lundberg KJ, Renshaw PF: A review of treatment options for co-occurring methamphetamine use disorders and depression. J Addict Nurs 2015; 26: 14–23 CrossRef MEDLINE
23. Sherman SG, Sutcliffe C, Srirojn B, Latkin CA, Aramratanna A, Celentano DD: Evaluation of a peer network intervention trial among young methamphetamine users in Chiang Mai, Thailand. Soc Sci Med 2009; 68: 69–79 CrossRef MEDLINE PubMed Central